These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 29945959)
1. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression. Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959 [TBL] [Abstract][Full Text] [Related]
2. SCF Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683 [TBL] [Abstract][Full Text] [Related]
3. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155 [TBL] [Abstract][Full Text] [Related]
4. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221 [TBL] [Abstract][Full Text] [Related]
5. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701 [TBL] [Abstract][Full Text] [Related]
6. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis. Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway. Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251 [TBL] [Abstract][Full Text] [Related]
8. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition. Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981 [TBL] [Abstract][Full Text] [Related]
9. SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis. Liu Y; Zhou H; Zhu R; Ding F; Li Y; Cao X; Liu Z Oncogene; 2018 Feb; 37(6):768-776. PubMed ID: 29059170 [TBL] [Abstract][Full Text] [Related]
10. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer. Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174 [TBL] [Abstract][Full Text] [Related]
11. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells. Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066 [TBL] [Abstract][Full Text] [Related]
12. Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer. Zhou Y; Shurin GV; Zhong H; Bunimovich YL; Han B; Shurin MR Cancer Res; 2018 Oct; 78(20):5927-5939. PubMed ID: 30135194 [TBL] [Abstract][Full Text] [Related]
13. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis. Johmura Y; Harris AS; Ohta T; Nakanishi M Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008 [TBL] [Abstract][Full Text] [Related]
14. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression. Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183 [TBL] [Abstract][Full Text] [Related]
15. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
16. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761 [TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment. Ray R; Jangde N; Singh SK; Sinha S; Rai V Cell Commun Signal; 2020 Oct; 18(1):170. PubMed ID: 33109194 [TBL] [Abstract][Full Text] [Related]
18. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma. Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279 [TBL] [Abstract][Full Text] [Related]
19. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21. Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376 [TBL] [Abstract][Full Text] [Related]
20. Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis. Zhang J; Lin X; Wu L; Huang JJ; Jiang WQ; Kipps TJ; Zhang S Oncogene; 2020 Mar; 39(12):2550-2567. PubMed ID: 31996785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]